TU H CAO

Allopathic & Osteopathic Physicians|Family Medicine PHOENIX, MD NPI 1063607232

General Payments — all program years on this page

$3,924.06

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 78
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $631.85 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $631.8520

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $178.495
Acerta Pharma LLC $176.405
ABIOMED $80.611
PFIZER INC. $58.853
Exact Sciences Corporation $53.742
Boehringer Ingelheim Pharmaceuticals, Inc. $25.631
Astellas Pharma US Inc $23.491
Lilly USA, LLC $18.641
ABBVIE INC. $16.001

By program year

Program yearAmountRecords
2018 $682.4216
2019 $188.982
2020 $18.721
2021 $936.8015
2022 $982.5318
2023 $482.766
2024 $631.8520

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096849475 Novo Nordisk Inc $23.82 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096977215 Novo Nordisk Inc $5.82 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097233153 Novo Nordisk Inc $23.76 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097307397 Novo Nordisk Inc $7.20 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097607858 Novo Nordisk Inc $117.89 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103413365 ABBVIE INC. $16.00 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104327176 AstraZeneca Pharmaceuticals LP $22.87 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104350192 AstraZeneca Pharmaceuticals LP $26.04 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104554054 AstraZeneca Pharmaceuticals LP $19.77 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105563496 AstraZeneca Pharmaceuticals LP $0.62 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105868857 AstraZeneca Pharmaceuticals LP $107.10 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114606934 Exact Sciences Corporation $25.80 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114606938 Exact Sciences Corporation $27.94 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117858371 Boehringer Ingelheim Pharmaceuticals, Inc. $25.63 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131056155 PFIZER INC. $23.88 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131824508 PFIZER INC. $20.45 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131963324 PFIZER INC. $14.52 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135439500 Lilly USA, LLC $18.64 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139296884 Astellas Pharma US Inc $23.49 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142296069 ABIOMED $80.61 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.